Elizabeth Head

Affiliations: 
Sanders Brown Center on Aging University of Kentucky, Lexington, KY 
Area:
brain aging and dementia
Google:
"Elizabeth Head"
Mean distance: 15.66 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pivtoraiko VN, Racic T, Abrahamson EE, et al. (2021) Postmortem Neocortical H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer's Disease. Frontiers in Aging Neuroscience. 13: 728739
Carmona-Iragui M, Alcolea D, Barroeta I, et al. (2021) Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study. The Lancet. Neurology. 20: 605-614
Hendrix JA, Amon A, Abbeduto L, et al. (2021) Opportunities, barriers, and recommendations in down syndrome research. Translational Science of Rare Diseases. 5: 99-129
Morabito S, Miyoshi E, Michael N, et al. (2021) Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer's disease. Nature Genetics
Lemere CA, Head E, Holtzman DM. (2021) APOE ε4 Association With Cognition and Alzheimer Disease Biomarkers in Down Syndrome-Implications for Clinical Trials and Treatments for All. Jama Neurology
Aschenbrenner AJ, Baksh RA, Benejam B, et al. (2021) Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12184
Radhakrishnan H, Ubele M, Krumholz SM, et al. (2021) Tacrolimus protects against age-associated microstructural changes in the beagle brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Hendrix JA, Airey DC, Britton A, et al. (2021) Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study. Journal of Clinical Medicine. 10
Petersen ME, Rafii MS, Zhang F, et al. (2020) Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome. Journal of Alzheimer's Disease : Jad
Koehl L, Harp J, Van Pelt KL, et al. (2020) Longitudinal assessment of dementia measures in Down syndrome. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12075
See more...